Kraig Biocraft and Kings Group form Spydasilk Enterprises

April 13th, 2021

Kraig Biocraft Laboratories Inc., a biotechnology company focused on the development and commercialization of spider silk, has announced that the company, together with M the Movement, Kings Golden Harvest Pte Ltd (“Kings Group”), has established Spydasilk Enterprises Pte. Ltd. (“Spydasilk Enterprises”) as a Singapore-based joint venture. This partnership represents the company’s first vertically integrated sales […]

Read More

Kraig Biocraft secures expansion capital

March 31st, 2021

Kraig Biocraft Laboratories Inc. announced that it has secured $4 million dollars of expansion capital. The financing significantly strengthens the company’s balance sheet and supports its progress in the commercialization and sale of recombinant spider silk. “This is a major financial milestone for Kraig. For many years we have operated on a shoestring budget, building […]

Read More

Kraig Biocraft Laboratories secures bridge funding

December 17th, 2020

Kraig Biocraft Laboratories Inc. has secured $950,000 in bridge financing and simultaneously filed with the SEC to become a mandatory, fully reporting company. The company recently filed a Form 8-A to become a fully reporting issuer. “While being a voluntary filer, Kraig has been committed to meeting all SEC filing and reporting standards. Our election […]

Read More

Kraig Biocraft readies shipment for spider silk production

November 24th, 2020

Kraig Biocraft Laboratories Inc. has announced that it has completed production and genetic screening of its latest batch of spider silk silkworm eggs.  These specialized silkworm eggs are now ready for shipment to Vietnam to restart commercial production.  Production operations at the company’s factory were suspended in March due to a mandatory shutdown, resulting from […]

Read More